Microencapsulation of cellular aggregates composed of differentiated insulin and glucagon-producing cells from human mesenchymal stem cells derived from adipose tissue.

Claudia JaraFelipe Oyarzun-AmpueroFlavio CarriónEsteban González-EcheverríaClaudio CappelliPablo Caviedes

Published in: Diabetology & metabolic syndrome (2020)

The IPC/GPC differentiation process from hASC, followed by the generation of cellular aggregates that are later microencapsulated, could represent a possible treatment for T1DM.

Keyphrases

adipose tissue
mesenchymal stem cells
endothelial cells
type diabetes
glycemic control
insulin resistance
umbilical cord
high fat diet
induced pluripotent stem cells
pluripotent stem cells
combination therapy
stem cells
cell therapy